[PDF][PDF] Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data

…, BJ Law, U Munro, HC Maltezou, P Nell, J Oleske… - Vaccine, 2011 - researchgate.net
The findings, opinions, conclusions, and assertions contained in this consensus document
are those of the individual members of the Working Group. They do not necessarily represent …

Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study

JM Langley, JC LeBlanc, EEL Wang, BJ Law… - …, 1997 - publications.aap.org
Objective. To determine nosocomial transmission of respiratory syncytial virus (RSV) in
Canadian pediatric hospitals, outcomes associated with nosocomial disease, and infection …

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk …

…, RC Welliver, SA Chartrand, BJ Law… - The Pediatric …, 1999 - journals.lww.com
Respiratory syncytial virus (RSV), an RNA-containing virus of the Pneumovirus genus, is the
most important cause of bronchiolitis and pneumonia in infants and young children on a …

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory …

EEL Wang, BJ Law, D Stephens - The Journal of pediatrics, 1995 - Elsevier
Objective: To provide information on disease attributable to respiratory syncytial viral lower
respiratory tract infection (RSV LRI) and to quantify the morbidity associated with various risk …

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at …

BJ Law, JM Langley, U Allen, B Paes… - The Pediatric …, 2004 - journals.lww.com
Background: Infants born at 33 through 35 completed weeks of gestation (33-35GA) are at
risk for severe respiratory syncytial virus (RSV) infection, and palivizumab prophylaxis lowers …

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory …

EEL Wang, BJ Law, FD Boucher, D Stephens… - The Journal of …, 1996 - Elsevier
OBJECTIVES: To describe differences in patients hospitalized with respiratory syncytial
virus (RSV) lower respiratory tract infection (LRI) at nine Canadian tertiary care hospitals. In …

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial

NE MacDonald, SA Halperin, BJ Law, B Forrest… - Jama, 1998 - jamanetwork.com
Context.—Meningococcal polysaccharide vaccines are not used routinely in infants and
toddlers, the groups at highest risk of invasive disease, because of poor immunologic responses …

Evidence-based prescribing of antibiotics for children: role of socioeconomic status and physician characteristics

…, DG Chateau, GB Mazowita, TP Klassen, BJ Law - Cmaj, 2004 - Can Med Assoc
Background: Evidence-based guidelines for antibiotic use are well established, but
nonadherence to these guidelines continues. This study was undertaken to determine child, …

Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003–2004

…, P Déry, E Ford-Jones, HM Arishi, BJ Law… - …, 2006 - publications.aap.org
OBJECTIVES. Influenza is a common childhood infection that may result in hospitalization.
Our objectives were to (1) determine characteristics of children hospitalized for influenza and …

Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) …

JM Langley, EEL Wang, BJ Law, D Stephens… - The Journal of …, 1997 - Elsevier
Objectives: To quantify the cost and distribution of health care resources consumed annually
in management of Canadian children from birth to 4 years of age with respiratory syncytial …